The purpose of this study is to see if a telemedicine group doctor's appointment is a practical (feasible) and acceptable method for following people with prostate cancer being managed with active surveillance when compared with the usual approach of individual telemedicine visits, which involve the participant visiting a doctor on their own. The researchers will compare the telemedicine group and individual visits by measuring on participant satisfaction and quality of life in each type of visit. Telemedicine is the use of secure video technology on a desktop computer, laptop, smartphone, or tablet to provide and receive healthcare from a distance.
A scheduled appointment for a subsequent Active Surveillance (AS) follow-up visit for management of localized prostate cancer Biopsy Gleason score 3+3=6 (Grade Group 1) or biopsy Gleason score 3+4=7 (Grade Group 2) Clinical T stage ≤T2B Access to a device with Zoom Ability to speak and understand English
Exclusion Criteria:
Plan to undergo a prostate biopsy at this follow-up visit
